Gai J, File M, Erdei R, Czajlik A, Marx F, Galgóczy L, Váradi G, Batta G. Small
Disulfide Proteins with Antifungal Impact: NMR Experimental Structures as Compared to Models of Alphafold
Versions. Int J Mol Sci. 2025 Jan 31;26(3):1247. doi: 10.3390/ijms26031247. PMID: 39941016; PMCID: PMC11818080.
PubMed
2024:
Bende G, Zsindely N, Laczi K, Kristóffy Z, Papp C, Farkas A, Tóth L, Sáringer S,
Bodai L, Rákhely G, Marx F, Galgóczy L. The Neosartorya (Aspergillus) fischeri antifungal protein NFAP2 has low
potential to trigger resistance development in Candida albicans in vitro. Microbiol Spectr. 2025 Jan
7;13(1):e0127324. doi: 10.1128/spectrum.01273-24. Epub 2024 Nov 19. PMID: 39560388; PMCID: PMC11705825. PubMed
Pavela O, Juhász T, Tóth L, Czajlik A, Batta G, Galgóczy L, Beke-Somfai T. Mapping
of the Lipid-Binding Regions of the Antifungal Protein NFAP2 by Exploiting Model Membranes. J Chem Inf Model.
2024 Aug 26;64(16):6557-6569. doi: 10.1021/acs.jcim.4c00229. Epub 2024 Aug 16. PMID: 39150323; PMCID:
PMC11351017. PubMed
Dán K, Kocsubé S, Tóth L, Farkas A, Rákhely G, Galgóczy L. Isolation and
identification of fungal biodeteriogens from the wall of a cultural heritage church and potential applicability
of antifungal proteins in protection. J. Cult. Herit. 2024;67:194-202. doi: 10.1016/j.culher.2024.03.002. Link
Váradi G, Bende G, Borics A, Dán K, Rákhely G, Tóth GK, Galgóczy L. Rational Design
of Antifungal Peptides Based on the γ-Core Motif of a Neosartorya (Aspergillus) fischeri
Antifungal Protein to
Improve Structural Integrity, Efficacy, and Spectrum. ACS Omega. 2024 Jan 31;9(6):7206-7214. doi:
10.1021/acsomega.3c09377. PMID: 38371770; PMCID: PMC10870298. PubMed
2023:
Váradi G, Kele Z, Czajlik A, Borics A, Bende G, Papp C, Rákhely G, Tóth GK, Batta G,
Galgóczy L. Hard nut to crack: Solving the disulfide linkage pattern of the Neosartorya (Aspergillus) fischeri
antifungal protein 2. Protein Sci. 2023 Jul;32(7):e4692. doi: 10.1002/pro.4692. PMID: 37272210; PMCID:
PMC10273333. PubMed
Váradi G, Batta G, Galgóczy L, Hajdu D, Fizil Á, Czajlik A, Virágh M, Kele Z, Meyer
V, Jung S, Marx F, Tóth GK. Confirmation of the Disulfide Connectivity and Strategies for Chemical Synthesis of
the Four-Disulfide-Bond-Stabilized Aspergillus giganteus Antifungal Protein, AFP. J Nat Prod. 2023 Apr
28;86(4):782-790. doi: 10.1021/acs.jnatprod.2c00954. Epub 2023 Feb 27. PMID: 36847642; PMCID: PMC10152477. PubMed
2022:
Kakar A, Sastré-Velásquez LE, Hess M, Galgóczy L, Papp C, Holzknecht J, Romanelli A,
Váradi G, Malanovic N, Marx F. The Membrane Activity of the Amphibian Temporin B Peptide Analog TB_KKG6K Sheds
Light on the Mechanism That Kills Candida albicans. mSphere. 2022 Oct 26;7(5):e0029022. doi:
10.1128/msphere.00290-22. Epub 2022 Aug 16. PMID: 35972132; PMCID: PMC9599520.
PubMed
Váradi G, Galgóczy L, Tóth GK. Rationally Designed Antimicrobial Peptides Are
Potential Tools to Combat Devastating Bacteria and Fungi. Int J Mol Sci. 2022 Jun 2;23(11):6244. doi:
10.3390/ijms23116244. PMID: 35682921; PMCID: PMC9181708.
PubMed
Holzknecht J, Dubrac S, Hedtrich S, Galgóczy L, Marx F. Small, Cationic Antifungal
Proteins from Filamentous Fungi Inhibit Candida albicans Growth in 3D Skin Infection Models. Microbiol Spectr.
2022 Jun 29;10(3):e0029922. doi: 10.1128/spectrum.00299-22. Epub 2022 May 2. PMID: 35499318; PMCID: PMC9241769.
PubMed
Tóth L, Poór P, Ördög A, Váradi G, Farkas A, Papp C, Bende G, Tóth GK, Rákhely G, Marx F, Galgóczy L. The
combination of Neosartorya (Aspergillus) fischeri antifungal proteins
with rationally designed γ-core peptide derivatives is effective for plant and crop protection. Biocontrol
(Dordr). 2022;67(2):249-262. doi: 10.1007/s10526-022-10132-y. Epub 2022 Feb 4. PMID: 35463117; PMCID:
PMC8993730.
PubMed
2021:
Gandía M, Kakar A, Giner-Llorca M, Holzknecht J, Martínez-Culebras P,
Galgóczy L, Marx F, Marcos JF, Manzanares P. Potential of Antifungal
Proteins (AFPs) to Control Penicillium
Postharvest Fruit Decay. J Fungi (Basel). 2021 Jun 4;7(6):449. doi:
10.3390/jof7060449. PMID: 34199956; PMCID: PMC8229795.
PubMed
Czajlik A, Holzknecht J, Galgóczy L, Tóth L, Poór P, Ördög A, Váradi
G, Kühbacher A, Borics A, Tóth GK, Marx F, Batta G. Solution
structure, dynamics, and new antifungal aspects of the cysteine-rich
miniprotein PAFC. Int J Mol Sci. 2021 Jan 25;22(3):1183. doi:
10.3390/ijms22031183. PMID: 33504082; PMCID: PMC7865535.
PubMed
Kovács R, Nagy F, Tóth Z, Forgács L, Tóth L, Váradi G, Tóth GK,
Vadászi K, Borman AM, Majoros L, Galgóczy L. The
Neosartorya fischeri antifungal protein 2 (NFAP2): A new
potential weapon against multidrug-resistant
Candida auris biofilms. Int J Mol Sci. 2021 Jan 14;22(2):771.
doi: 10.3390/ijms22020771. PMID: 33466640; PMCID: PMC7828714.
PubMed
2020:
Holzknecht J, Kühbacher A, Papp C, Farkas A, Váradi G, Marcos JF,
Manzanares P, Tóth GK, Galgóczy L, Marx F. The
Penicillium chrysogenum Q176 antimicrobial protein PAFC
effectively inhibits the growth of the opportunistic human pathogen
Candida albicans. J Fungi (Basel). 2020 Aug 19;6(3):141. doi:
10.3390/jof6030141. PMID: 32824977; PMCID: PMC7557831.
PubMed
Tóth L, Váradi G, Boros É, Borics A, Ficze H, Nagy I, Tóth GK, Rákhely
G, Marx F, Galgóczy L. Biofungicidal potential of
Neosartorya (Aspergillus) fischeri antifungal protein NFAP and
novel synthetic γ-Core Peptides. Front Microbiol. 2020 May 13;11:820.
doi: 10.3389/fmicb.2020.00820. PMID: 32477291; PMCID: PMC7237641.
PubMed
Tóth L, Boros É, Poór P, Ördög A, Kele Z, Váradi G, Holzknecht J,
Bratschun-Khan D, Nagy I, Tóth GK, Rákhely G, Marx F, Galgóczy L. The
potential use of the Penicillium chrysogenum antifungal
protein PAF, the designed variant PAFopt and its γ-core peptide Pγopt
in plant protection. Microb Biotechnol. 2020 Sep;13(5):1403-1414. doi:
10.1111/1751-7915.13559. Epub 2020 Mar 24. PMID: 32207883; PMCID:
PMC7415367.
PubMed
Huber A, Galgóczy L, Váradi G, Holzknecht J, Kakar A, Malanovic N,
Leber R, Koch J, Keller MA, Batta G, Tóth GK, Marx F. Two small,
cysteine-rich and cationic antifungal proteins from
Penicillium chrysogenum: A comparative study of PAF and PAFB. Biochim Biophys Acta Biomembr.
2020 Aug 1;1862(8):183246. doi: 10.1016/j.bbamem.2020.183246. Epub
2020 Mar 3. PMID: 32142818; PMCID: PMC7138148.
PubMed
2019:
Galgóczy L, Yap A, Marx F. Cysteine-rich antifungal proteins from
filamentous fungi are promising bioactive natural compounds in anti-Candida
therapy. Isr J Chem. 2019 May;59(5):360-370. doi:
10.1002/ijch.201800168. Epub 2019 Feb 20. PMID: 31680702; PMCID:
PMC6813639.
PubMed
Hajdu D, Huber A, Czajlik A, Tóth L, Kele Z, Kocsubé S, Fizil Á, Marx
F, Galgóczy L, Batta G. Solution structure and novel insights into
phylogeny and mode of action of the
Neosartorya (Aspergillus) fischeri antifungal protein (NFAP).
Int J Biol Macromol. 2019 May 15;129:511-522. doi:
10.1016/j.ijbiomac.2019.02.016. Epub 2019 Feb 7. PMID: 30738898.
PubMed
Kovács R, Holzknecht J, Hargitai Z, Papp C, Farkas A, Borics A, Tóth
L, Váradi G, Tóth GK, Kovács I, Dubrac S, Majoros L, Marx F, Galgóczy
L. In vivo applicability of
Neosartorya fischeri antifungal protein 2 (NFAP2) in treatment
of vulvovaginal candidiasis. Antimicrob Agents Chemother. 2019 Jan
29;63(2):e01777-18. doi: 10.1128/AAC.01777-18. PMID: 30478163; PMCID:
PMC6355578.
PubMed
Galgóczy L, Marx F. Do Antimicrobial proteins contribute to overcoming
the hidden antifungal crisis at the dawn of a post-antibiotic era?
Microorganisms. 2019 Jan 11;7(1):16. doi:
10.3390/microorganisms7010016. PMID: 30641886; PMCID: PMC6352135.
PubMed
2018:
Sonderegger C, Váradi G, Galgóczy L, Kocsubé S, Posch W, Borics A,
Dubrac S, Tóth GK, Wilflingseder D, Marx F. The evolutionary conserved
γ-core motif influences the anti-Candida activity of the
Penicillium chrysogenum antifungal protein PAF. Front
Microbiol. 2018 Jul 20;9:1655. doi: 10.3389/fmicb.2018.01655. PMID:
30079061; PMCID: PMC6062912.
PubMed
Tóth L, Váradi G, Borics A, Batta G, Kele Z, Vendrinszky Á, Tóth R,
Ficze H, Tóth GK, Vágvölgyi C, Marx F, Galgóczy L. Anti-Candidal
activity and functional mapping of recombinant and synthetic
Neosartorya fischeri antifungal protein 2 (NFAP2). Front
Microbiol. 2018 Mar 7;9:393. doi: 10.3389/fmicb.2018.00393. PMID:
29563903; PMCID: PMC5845869.
PubMed
Huber A, Hajdu D, Bratschun-Khan D, Gáspári Z, Varbanov M, Philippot
S, Fizil Á, Czajlik A, Kele Z, Sonderegger C, Galgóczy L, Bodor A,
Marx F, Batta G. New antimicrobial potential and structural properties
of PAFB: A cationic, cysteine-rich protein from
Penicillium chrysogenum Q176. Sci Rep. 2018 Jan
29;8(1):1751. doi: 10.1038/s41598-018-20002-2. PMID: 29379111; PMCID:
PMC5788923.
PubMed
2017:
Galgóczy L, Borics A, Virágh M, Ficze H, Váradi G, Kele Z, Marx F.
Structural determinants of Neosartorya fischeri antifungal
protein (NFAP) for folding, stability and antifungal activity. Sci
Rep. 2017 May 16;7(1):1963. doi: 10.1038/s41598-017-02234-w. PMID:
28512317; PMCID: PMC5434006.
PubMed
2016:
Tóth L, Kele Z, Borics A, Nagy LG, Váradi G, Virágh M, Takó M,
Vágvölgyi C, Galgóczy L. NFAP2, a novel cysteine-rich anti-yeast
protein from Neosartorya fischeri NRRL 181: isolation and
characterization. AMB Express. 2016 Dec;6(1):75. doi:
10.1186/s13568-016-0250-8. Epub 2016 Sep 15. PMID: 27637945; PMCID:
PMC5025423.
PubMed
Sonderegger C, Galgóczy L, Garrigues S, Fizil Á, Borics A, Manzanares
P, Hegedüs N, Huber A, Marcos JF, Batta G, Marx F. A
Penicillium chrysogenum-based expression system for the
production of small, cysteine-rich antifungal proteins for structural
and functional analyses. Microb Cell Fact. 2016 Nov 11;15(1):192. doi:
10.1186/s12934-016-0586-4. PMID: 27835989; PMCID: PMC5106836.
PubMed
2015:
Virágh M, Marton A, Vizler C, Tóth L, Vágvölgyi C, Marx F, Galgóczy L.
Insight into the antifungal mechanism of
Neosartorya fischeri antifungal protein. Protein Cell. 2015
Jul;6(7):518-28. doi: 10.1007/s13238-015-0167-z. Epub 2015 May 22.
PMID: 25994413; PMCID: PMC4491047.
PubMed
2014:
Virágh M, Vörös D, Kele Z, Kovács L, Fizil Á, Lakatos G, Maróti G,
Batta G, Vágvölgyi C, Galgóczy L. Production of a defensin-like
antifungal protein NFAP from Neosartorya fischeri in
Pichia pastoris and its antifungal activity against filamentous
fungal isolates from human infections. Protein Expr Purif. 2014
Feb;94:79-84. doi: 10.1016/j.pep.2013.11.003. Epub 2013 Nov 19. PMID:
24269762.
PubMed
2013:
Váradi G, Tóth GK, Kele Z, Galgóczy L, Fizil Á, Batta G. Synthesis of
PAF, an antifungal protein from P. chrysogenum, by native
chemical ligation: native disulfide pattern and fold obtained upon
oxidative refolding. Chemistry. 2013 Sep 16;19(38):12684-92. doi:
10.1002/chem.201301098. PMID: 24175344.
PubMed
Galgóczy L, Kovács L, Karácsony Z, Virágh M, Hamari Z, Vágvölgyi C.
Investigation of the antimicrobial effect of
Neosartorya fischeri antifungal protein (NFAP) after
heterologous expression in Aspergillus nidulans. Microbiology
(Reading). 2013 Feb;159(Pt 2):411-419. doi: 10.1099/mic.0.061119-0.
Epub 2012 Nov 29. PMID: 23197172.
PubMed
Galgóczy L, Virágh M, Kovács L, Tóth L, Vágvölgyi Cs. Potential
applications of filamentous fungus derived β-defensin-like antifungal
proteins in agriculture. Rev Agr Rural Develop. 2013 May; 2(1):
217-223.
Galgóczy L, Virágh M, Kovács L, Tóth B, Papp T, Vágvölgyi C.
Antifungal peptides homologous to the
Penicillium chrysogenum antifungal protein (PAF) are widespread
among Fusaria. Peptides. 2013 Jan;39:131-7. doi:
10.1016/j.peptides.2012.10.016. Epub 2012 Nov 19. PMID: 23174348.
PubMed
2011:
Kovács L, Virágh M, Takó M, Papp T, Vágvölgyi C, Galgóczy L. Isolation
and characterization of Neosartorya fischeri antifungal protein
(NFAP). Peptides. 2011 Aug;32(8):1724-31. doi:
10.1016/j.peptides.2011.06.022. Epub 2011 Jun 30. PMID: 21741420.
PubMed
2008:
Galgóczy L, Papp T, Pócsi I, Hegedus N, Vágvölgyi C.
In vitro activity of Penicillium chrysogenum antifungal
protein (PAF) and its combination with fluconazole against different
dermatophytes. Antonie Van Leeuwenhoek. 2008 Oct;94(3):463-70. doi:
10.1007/s10482-008-9263-x. Epub 2008 Jun 24. PMID: 18574706.
PubMed
2007:
Galgóczy L, Papp T, Lukács G, Leiter E, Pócsi I, Vágvölgyi C.
Interactions between statins and
Penicillium chrysogenum antifungal protein (PAF) to inhibit the
germination of sporangiospores of different sensitive Zygomycetes.
FEMS Microbiol Lett. 2007 May;270(1):109-15. doi:
10.1111/j.1574-6968.2007.00661.x. Epub 2007 Feb 16. PMID: 17302920.
PubMed
2005:
Galgóczy L, Papp T, Leiter E, Marx F, Pócsi I, Vágvölgyi C.
Sensitivity of different zygomycetes to the
Penicillium chrysogenum antifungal protein (PAF). J Basic
Microbiol. 2005;45(2):136-41. doi: 10.1002/jobm.200410512. PMID:
15812858.
PubMed
Database submissions of antifungal protein structures from publications
Solution structure of the antifungal protein NFAP2 (RCS Protein Data Bank: 8RP9)
Solution structure of the antifungal protein PAFC (RCS Protein Data
Bank:
6TRM)
Solution structure of antifungal protein NFAP (RCS Protein Data Bank:
5OQS)
Solution structure of the antifungal protein PAFB (RCS Protein Data
Bank:
2NC2)
Other publications
2024:
Kukri A, Czékus Z, Gallé Á, Nagy G, Zsindely N, Bodai L, Galgóczy L, Hamow KÁ,
Szalai G, Ördög A, Poór P. Exploring the effects of red light night break on the defence mechanisms of tomato
against fungal pathogen Botrytis cinerea. Physiol Plant. 2024 Jul-Aug;176(4):e14504. doi:
10.1111/ppl.14504.
PMID: 39191700. PubMed
Földi C, Merényi Z, Balázs B, Csernetics Á, Miklovics N, Wu H, Hegedüs B, Virágh M, Hou Z, Liu X-B, Galgóczy L,
Nagy LG. Snowball: a novel gene family required for developmental patterning of fruiting bodies of
mushroom-forming fungi (Agaricomycetes). mSystems. 2024 Mar 19;9(3):e0120823. doi: 10.1128/msystems.01208-23.
Epub 2024 Feb 9. PMID: 38334416; PMCID: PMC10949477.
PubMed
2021:
Gallé Á, Czékus Z, Tóth L, Galgóczy L, Poór P. Pest and disease
management by red light. Plant Cell Environ. 2021 Jun 30. doi:
10.1111/pce.14142. Epub ahead of print. PMID: 34191305.
PubMed
2019:
Nagy G, Vaz AG, Szebenyi C, Takó M, Tóth EJ, Csernetics Á, Bencsik O,
Szekeres A, Homa M, Ayaydin F, Galgóczy L, Vágvölgyi C, Papp T.
CRISPR-Cas9-mediated disruption of the HMG-CoA reductase genes of
Mucor circinelloides and subcellular localization of the
encoded enzymes. Fungal Genet Biol. 2019 Aug;129:30-39. doi:
10.1016/j.fgb.2019.04.008. Epub 2019 Apr 13. PMID: 30991115.
PubMed
2018:
Homa M, Galgóczy L, Manikandan P, Narendran V, Sinka R, Csernetics Á,
Vágvölgyi C, Kredics L, Papp T. South Indian isolates of the
Fusarium solani species complex from clinical and environmental
samples: Identification, antifungal susceptibilities, and virulence.
Front Microbiol. 2018 May 23;9:1052. doi: 10.3389/fmicb.2018.01052.
PMID: 29875757; PMCID: PMC5974209.
PubMed
Homa M, Manikandan P, Saravanan V, Revathi R, Anita R, Narendran V,
Panneerselvam K, Shobana CS, Aidarous MA, Galgóczy L, Vágvölgyi C,
Papp T, Kredics L. Exophiala dermatitidis endophthalmitis: Case
report and literature review. Mycopathologia. 2018 Jun;183(3):603-609.
doi: 10.1007/s11046-017-0235-4. Epub 2018 Jan 27. PMID: 29374798.
PubMed
2017:
Homa M, Hegedűs K, Fülöp Á, Wolfárt V, Kadaikunnan S, Khaled JM,
Alharbi NS, Vágvölgyi C, Galgóczy L. In vitro activity of
calcium channel blockers in combination with conventional antifungal
agents against clinically important filamentous fungi. Acta Biol Hung.
2017
Jensen K, Lund KP, Christensen KB, Holm AT, Dubey LK, Moeller JB,
Jepsen CS, Schlosser A, Galgóczy L, Thiel S, Holmskov U, Sorensen GL.
M-ficolin is present in Aspergillus fumigatus infected lung and
modulates epithelial cell immune responses elicited by fungal cell
wall polysaccharides. Virulence. 2017 Nov 17;8(8):1870-1879. doi:
10.1080/21505594.2016.1278337. Epub 2017 Feb 16. PMID: 28060571;
PMCID: PMC5810506.
PubMed
2016:
Homa M, Galgóczy L, Tóth E, Virágh M, Chandrasekaran M, Vágvölgyi C,
Papp T. In vitro susceptibility of Scedosporium isolates
to N-acetyl-L-cysteine alone and in combination with conventional
antifungal agents. Med Mycol. 2016 Oct 1;54(7):776-9. doi:
10.1093/mmy/myw029. Epub 2016 May 3. PMID: 27143635.
PubMed
Hassan AS, Al-Hatmi AM, Shobana CS, van Diepeningen AD, Kredics L,
Vágvölgyi C, Homa M, Meis JF, de Hoog GS, Narendran V, Manikandan P;
IHFK Working Group. Antifungal susceptibility and phylogeny of
opportunistic members of the genus Fusarium causing human
keratomycosis in South India. Med Mycol. 2016 Mar;54(3):287-94. doi:
10.1093/mmy/myv105. Epub 2015 Dec 24. PMID: 26705832.
PubMed
Galgóczy L, Homa M, Papp T, Manikandan P, Vágvölgyi Cs.
In vitro antifungal activity of cysteine derivatives and their
combinations with antifungal agents against clinically relevant
Scedosporium species. Int J Clin Med Microbiol. 2016;
1(2):Paper 111. doi: 10.15344/2456-4028/2016/111.
2015:
Krizsán K, Tóth E, Nagy LG, Galgóczy L, Manikandan P, Chandrasekaran
M, Kadaikunnan S, Alharbi NS, Vágvölgyi C, Papp T. Molecular
identification and antifungal susceptibility of
Curvularia australiensis, C. hawaiiensis and
C. spicifera isolated from human eye infections. Mycoses. 2015
Oct;58(10):603-9. doi: 10.1111/myc.12367. Epub 2015 Sep 8. PMID:
26345164.
PubMed
Homa M, Fekete IP, Böszörményi A, Singh YR, Selvam KP, Shobana CS,
Manikandan P, Kredics L, Vágvölgyi C, Galgóczy L. Antifungal effect of
essential oils against Fusarium keratitis isolates. Planta Med.
2015 Sep;81(14):1277-84. doi: 10.1055/s-0035-1546272. Epub 2015 Jul
30. PMID: 26227503.
PubMed
Homa M, Galgóczy L, Tóth E, Tóth L, Papp T, Chandrasekaran M,
Kadaikunnan S, Alharbi NS, Vágvölgyi C. In vitro antifungal
activity of antipsychotic drugs and their combinations with
conventional antifungals against Scedosporium and
Pseudallescheria isolates. Med Mycol. 2015 Nov;53(8):890-5.
doi: 10.1093/mmy/myv064. Epub 2015 Aug 26. PMID: 26316212.
PubMed
Kredics L, Narendran V, Shobana CS, Vágvölgyi C, Manikandan P;
Indo-Hungarian Fungal Keratitis Working Group. Filamentous fungal
infections of the cornea: a global overview of epidemiology and drug
sensitivity. Mycoses. 2015 Apr;58(4):243-60. doi: 10.1111/myc.12306.
Epub 2015 Feb 27. PMID: 25728367.
PubMed
Shobana CS, Mythili A, Homa M, Galgóczy L, Priya R, Babu Singh YR,
Panneerselvam K, Vágvölgyi C, Kredics L, Narendran V, Manikandan P.
In vitro susceptibility of filamentous fungi from mycotic
keratitis to azole drugs. J Mycol Med. 2015 Mar;25(1):44-9. doi:
10.1016/j.mycmed.2014.10.024. Epub 2014 Dec 22. PMID: 25541256.
PubMed
2014:
Galgóczy L, Guba M, Sajben E, Vörös M, Takó M, Tserennadmid R,
Vágvölgyi Cs. Antidermatophytic effect of
Bacillus mojavensis SZMC 22228 and its secreted
chymotrypsin-like protease. Acta Biol Szeged. 2014 Sep; 58(2):157-16.
Nyilasi I, Kocsubé S, Krizsán K, Galgóczy L, Papp T, Pesti M, Nagy K,
Vágvölgyi C. Susceptibility of clinically important dermatophytes
against statins and different statin-antifungal combinations. Med
Mycol. 2014 Feb;52(2):140-8. doi: 10.3109/13693786.2013.828160. PMID:
24004389.
PubMed
Homa M, Shobana CS, Singh YR, Manikandan P, Selvam KP, Kredics L,
Narendran V, Vágvölgyi C, Galgóczy L. Fusarium keratitis in
South India: causative agents, their antifungal susceptibilities and a
rapid identification method for the Fusarium solani species
complex. Mycoses. 2013 Sep;56(5):501-11. doi: 10.1111/myc.12062. Epub
2013 Feb 26. PMID: 23437826.
PubMed
2012:
Galgóczy L, Tóth L, Virágh M, Papp T, Vágvölgyi CS.
In vitro interactions of amantadine hydrochloride,
R-(-)-deprenyl hydrochloride and valproic acid sodium salt with
antifungal agents against filamentous fungal species causing central
nervous system infection. Acta Biol Hung. 2012 Dec;63(4):490-500. doi:
10.1556/ABiol.63.2012.4.8. PMID: 23134606.
PubMed
2011:
Galgóczy L, Nyilasi I, Papp T, Vágvölgyi C. Statins as antifungal
agents. World J Clin Infect Dis 2011 Dec 30; 1(1):4-10. doi:
10.5495/wjcid.v1.i1.4
Tserennadmid R, Takó M, Galgóczy L, Papp T, Pesti M, Vágvölgyi C,
Almássy K, Krisch J. Anti yeast activities of some essential oils in
growth medium, fruit juices and milk. Int J Food Microbiol. 2011 Jan
5;144(3):480-6. doi: 10.1016/j.ijfoodmicro.2010.11.004. Epub 2010 Nov
13. PMID: 21131081.
PubMed
Galgóczy L, Guba M, Papp T, Krisch J, Vágvölgyi Cs, Tserennadmid R.
In vitro antibacterial effect of a mumijo preparation from
Mongolia. Afr J Microbiol Res. 2011 Oct; 5(22):3832-3835. doi:
10.5897/AJMR11.798
Galgóczy L, Bácsi A, Homa M, Virágh M, Papp T, Vágvölgyi C.
In vitro antifungal activity of phenothiazines and their
combination with amphotericin B against different
Candida species. Mycoses. 2011 Nov;54(6):e737-43. doi:
10.1111/j.1439-0507.2010.02010.x. Epub 2011 May 23. PMID: 21605196.
PubMed
2010:
Krizsán K, Bencsik O, Nyilasi I, Galgóczy L, Vágvölgyi C, Papp T.
Effect of the sesterterpene-type metabolites, ophiobolins A and B, on
zygomycetes fungi. FEMS Microbiol Lett. 2010 Dec;313(2):135-40. doi:
10.1111/j.1574-6968.2010.02138.x. Epub 2010 Nov 4. PMID: 21054501.
PubMed
Galgóczy L, Lukács G, Nyilasi I, Papp T, Vágvölgyi C. Antifungal
activity of statins and their interaction with amphotericin B against
clinically important Zygomycetes. Acta Biol Hung. 2010
Sep;61(3):356-65. doi: 10.1556/ABiol.61.2010.3.11. PMID: 20724281.
PubMed
Tserennadmid R, Takó M, Galgóczy L, Papp T, Vágvölgyi Cs, Gerő L,
Krisch J. Antibacterial effect of essential oils and interaction with
food components. Cent Eur J Biol. 2014 June 24; 5(5):641-648. doi:
10.1111/j.1750-3841.2012.02956.x.
Nyilasi I, Kocsubé S, Krizsán K, Galgóczy L, Pesti M, Papp T,
Vágvölgyi C. In vitro synergistic interactions of the effects
of various statins and azoles against some clinically important fungi.
FEMS Microbiol Lett. 2010 Jun;307(2):175-84. doi:
10.1111/j.1574-6968.2010.01972.x. PMID: 20636975.
PubMed
Ördögh L, Galgóczy L, Krisch J, Papp T, Vágvölgyi Cs. Antioxidant and
antimicrobial activities of fruit juices and pomace extracts against
acne-inducing bacteria. Acta Biol Szeged. 2010 May; 54(1):45-49.
Nyilasi I, Kocsubé S, Galgóczy L, Papp T, Pesti M, Vágvölgyi Cs.
Effect of different statins on the antifungal activity of polyene
antimycotics. Acta Biol Szeged. 2010 May; 54(1):33-36.
2009:
Galgóczy L, Ördögh L, Virágh M, Papp T, Vágvölgyi Cs.
In vitro susceptibility of clinically important zygomycetes to
combinations of amphotericin B and suramin. J Med Mycol. 2009 Dec;
19(4):241-247. doi: 10.1016/j.mycmed.2009.09.004.
Galgóczy L, Papp T, Vágvölgyi C. In vitro interaction between
suramin and fluvastatin against clinically important Zygomycetes.
Mycoses. 2009 Sep;52(5):447-53. doi: 10.1111/j.1439-0507.2008.01634.x.
Epub 2008 Oct 22. PMID: 18983427.
PubMed
Galgóczy L, Kovács L, Krizsán K, Papp T, Vágvölgyi C. Inhibitory
effects of cysteine and cysteine derivatives on germination of
sporangiospores and hyphal growth of different Zygomycetes.
Mycopathologia. 2009 Sep;168(3):125-34. doi:
10.1007/s11046-009-9204-x. Epub 2009 Apr 19. PMID: 19381868.
PubMed
Galgóczy L, Nyilasi I, Papp T, Vágvölgyi C. Are statins applicable for
the prevention and treatment of zygomycosis? Clin Infect Dis. 2009 Aug
1;49(3):483; author reply 484-5. doi: 10.1086/600825. PMID: 19586402.
PubMed
Galgóczy L, Papp T, Kovács L, Ordögh L, Vágvölgyi C. In vitro activity
of phenothiazines and their combinations with amphotericin B against
Zygomycetes causing rhinocerebral zygomycosis. Med Mycol. 2009
May;47(3):331-5. doi: 10.1080/13693780802378853. Epub 2008 Sep 16.
PMID: 18798117.
PubMed
Galgóczy L, Vágvölgyi C. Antifungal peptides secreted by filamentous
fungi as promising new agents in human therapy. Future Microbiol. 2009
Apr;4(3):261-3. doi: 10.2217/fmb.09.2. PMID: 19327111.
PubMed
Galgóczy L, Hevér T, Orosz L, Krisch J, Vágvölgyi Cs, Tölgyesi M, Papp
T. Growth inhibition effect of fruit juices and pomace extracts on the
enteric pathogens Campylobacter jejuni and
Salmonella ser. Typhimurium. Int J Microbiol. 2009 Jan;
7(1):Paper 10c3. doi: 10.5580/10c3#sthash.xbMftqkr.dpuf.
Krisch J, Ördögh L, Galgóczy L, Papp T, Vágvölgyi Cs. Anticandidal
effect of berry juices and extracts from Ribes species. Cent
Eur J Biol. 2008 Dec 16; 4(1):86-89. doi: 10.2478/s11535-008-0056-z.
Malinovschi G, Kocsubé S, Galgóczy L, Somogyvári F, Vágvölgyi Cs.
Rapid PCR based identification of two medically important dermatophyte
fungi, Microsporum canis and Trichophyton tonsurans.
Acta Biol Szeged. 2009 Jan; 53(1):51-54.
Krisch J, Galgóczy L, Papp T, Vágvölgyi Cs. Antimicrobial and
antioxidant potential of waste products remaining after juice
pressing. Ann Fac Eng Hun – Int J Eng. 2009 Jan; 7:131-134.
2008:
Krisch J, Galgóczy L, Tölgyesi M, Papp T, Vágvölgyi Cs. Effect of
fruit juices and pomace extracts on the growth of Gram-positive and
Gram-negative bacteria. Acta Biol Szeged 2008 Dec; 52(2): 267-270.
Papp T, Nyilasi I, Csernetics Á, Galgóczy L, Vágvölgyi Cs. Molecular
studies on Zygomycetes fungi causing opportunistic infections. Rev Med
Mycol. 2008 April, 19(2):39-46. doi: 10.1097/MRM.0b013e32831a40f9.
Kocsubé S, Galgóczy L, Nagy GL, Farkas E, Vágvölgyi Cs.
In vitro evaluation of the anticandidal effect of Makó thermal
water. Cent Eur J Occ Env Med. 2008 Jan; 14(4):399-405.
2005:
Galgóczy L. Molecular characterization of opportunistic pathogenic
zygomycetes. Acta Biol Szeged. 2005 Jan; 49: 1-7.
2004:
Nagy A, Pesti M, Galgóczy L, Vágvölgyi C. Electrophoretic karyotype of
two Micromucor species. J Basic Microbiol. 2004;44(1):36-41.
doi: 10.1002/jobm.200310272. PMID: 14768026.
PubMed